secwatch.observer — SEC 8-K summary
======================================

Issuer:     CEL SCI CORP (CVM)
CIK:        0000725363
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001654954-23-005494
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEL-SCI prices $1.35M common stock offering at $1.70/share; net proceeds ~$1.12M to fund Multikine/LEAPS
--------------------------------------------------------------------------------

- Offering of 794,117 shares at $1.70 per share; gross proceeds ~$1.35M, net ~$1.12M after discounts and expenses.
- Spartan Capital Securities acting as sole book-running manager; 30-day over-allotment option for up to 119,117 additional shares.
- Expected to close on or about May 2, 2023; proceeds to fund continued development of Multikine and LEAPS and general corporate purposes.
- Offered under effective shelf registration S-3 (No. 333-265995) declared effective July 15, 2022; prospectus supplement filed April 27, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/725363/000165495423005494/0001654954-23-005494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/725363/000165495423005494/cvm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-005494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer